Navigation Links
Why is the measles virus so contagious?
Date:11/4/2011

An international collaboration involving Inserm has revealed how the measles virus leaves the body of an infected person to contaminate another individual. The researchers have identified a key receptor, located in the trachea, which allows the virus to spread through the air rapidly from one organism to another. The receptor, nectine-4, is also known to be a biomarker for some cancers.

This research appeared in a letter, dated 2 November 2011, published in Nature.

The measles virus is one of the most highly contagious human pathogens and can cause serious, sometimes fatal, complications. It is mainly transmitted when an infected person coughs or sneezes, sending droplets through the air to another individual. This explains why the virus spreads so rapidly through at-risk populations (i.e. persons who are not vaccinated or improperly vaccinated), obstructing world vaccination programmes that seek to eradicate it. Every year, this virus infects more than 10 million children and causes 120,000 deaths in the world. France also faces a measles epidemic that is giving cause for concern. While only forty or so cases were reported in 2006 and 2007, numbers have risen sharply since 2008 (14,600 cases have already been reported since the beginning of 2011) .

The discovery published in the journal Nature explains why this virus spreads so quickly. Viruses generally use cell receptors to initiate and spread the infection throughout the organism. This is the case of the measles virus, which infects the immune cells in the lungs to enter and spread through the body. For the first time ever, this study shows how the measles virus uses another receptor (nectine-4) to 'leave' its host. Nectine-4 is located specifically in the trachea, a part of the anatomy that is 'ideally' suited to airborne contagion.

Interesting prospects for cancer treatment

Nectine-4 is a biomarker for certain types of cancer, including breast, ovarian and lung cancer. Treatments based on the use of a modified vaccine strain of the measles virus are currently being developed for use against some cancers. This virus replicates preferentially in cancer cells, leading to their destruction. The presence of this biomarker in tumours must be taken into consideration to improve the efficacy of these novel therapeutic methods.


'/>"/>

Contact: Inserm Press Office
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related biology news :

1. Researchers test inhalable measles vaccine
2. Measles virus plays role in Pagets disease of bone, Pitt-led team says
3. Measles virus, a weapon against cancer?
4. Mayo researchers describe measles viral protein movement
5. West Nile virus transmission linked with land-use patterns and super-spreaders
6. Scientists report major advance in human antibody therapy against deadly Hendra virus
7. Pitt biologists find surprising number of unknown viruses in sewage
8. Manipulated gatekeeper: How viruses find their way into the cell nucleus
9. XMRV, related viruses not confirmed in blood of healthy donors or chronic fatigue syndrome patients
10. Cowpox virus: Old friend but new foe
11. Team finds stable RNA nano-scaffold within virus core
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
(Date:1/12/2017)... -- New research undertaken by Fit Small Business has ... were simply asked which office technology had they not used ... issue.  Insights on what will be key features ... and industry leaders including Penelope Trunk , Martin ... Some of these findings included; ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers and ... is a fully 21 CFR Part 11-compliant email client designed to provide product ...
(Date:1/19/2017)... Mass. , Jan. 19, 2017 AquaBounty ... focused on enhancing productivity in aquaculture and a majority-owned ... announces that it has completed the listing of its ... the equity subscription from Intrexon. "AquaBounty,s listing ... that will broaden our exposure to the U.S. markets ...
(Date:1/19/2017)... , ... January 19, 2017 , ... FireflySci Inc. is ... rate. The tremendous growth is accounted to two main factors. The first ... the expanding network of vendors supplying FireflySci products all around the world. , 2016 ...
(Date:1/19/2017)... Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ... immune therapies for operable and inoperable solid tumor cancers, ... Technical Officer of NW Bio, will present at the ... at the Hyatt Regency Hotel in Miami, ... the session entitled "New Therapeutic Approaches – Expanding the ...
Breaking Biology Technology: